Literature DB >> 12857736

Design of N-substituted peptomer ligands for EVH1 domains.

Jürgen Zimmermann1, Ronald Kühne, Rudolf Volkmer-Engert, Thomas Jarchau, Ulrich Walter, Hartmut Oschkinat, Linda J Ball.   

Abstract

Ena/VASP proteins are implicated in cytoskeletal reorganization during actin-dependent motility processes. Recruitment to subcellular sites of actin polymerization is mediated by the highly conserved N-terminal EVH1 domain, which interacts with target proteins containing proline-rich motifs. The VASP EVH1 domain specifically binds peptides with the consensus motif FPPPP present in all its binding partners, including the Listerial ActA protein. Previous studies have shown that the Phe and first and final Pro residues are highly conserved and cannot be substituted with any other natural amino acid without significant loss of binding affinity. We have incorporated peptoid building blocks (sarcosine derived, non-natural amino acids) into the peptide SFEFPPPPTEDEL from the Listerial ActA protein and were able to substitute the most highly conserved residues of this motif while maintaining binding to the VASP EVH1 domain with affinities in the range of 45-180 microm. We then used NMR chemical shift perturbations to locate specific domain residues involved in particular interactions. These studies may open up the way for designing selective modulators of VASP function for biological studies and for the development of novel therapeutics for diseases involving pathologically altered cell adhesion or cell motility.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857736     DOI: 10.1074/jbc.M305934200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  A modular toolkit to inhibit proline-rich motif-mediated protein-protein interactions.

Authors:  Robert Opitz; Matthias Müller; Cédric Reuter; Matthias Barone; Arne Soicke; Yvette Roske; Kirill Piotukh; Peter Huy; Monika Beerbaum; Burkhard Wiesner; Michael Beyermann; Peter Schmieder; Christian Freund; Rudolf Volkmer; Hartmut Oschkinat; Hans-Günther Schmalz; Ronald Kühne
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

2.  NMEGylation: a novel modification to enhance the bioavailability of therapeutic peptides.

Authors:  Minyoung Park; Theodore S Jardetzky; Annelise E Barron
Journal:  Biopolymers       Date:  2011       Impact factor: 2.505

3.  Miniature protein ligands for EVH1 domains: interplay between affinity, specificity, and cell motility.

Authors:  Jennifer H Holtzman; Kamil Woronowicz; Dasantila Golemi-Kotra; Alanna Schepartz
Journal:  Biochemistry       Date:  2007-11-01       Impact factor: 3.162

4.  A Consensus Binding Motif for the PP4 Protein Phosphatase.

Authors:  Yumi Ueki; Thomas Kruse; Melanie Bianca Weisser; Gustav N Sundell; Marie Sofie Yoo Larsen; Blanca Lopez Mendez; Nicole P Jenkins; Dimitriya H Garvanska; Lauren Cressey; Gang Zhang; Norman Davey; Guillermo Montoya; Ylva Ivarsson; Arminja N Kettenbach; Jakob Nilsson
Journal:  Mol Cell       Date:  2019-10-01       Impact factor: 17.970

5.  A readily applicable strategy to convert peptides to peptoid-based therapeutics.

Authors:  Minyoung Park; Modi Wetzler; Theodore S Jardetzky; Annelise E Barron
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.